REFERENCES
- Fioredda F, Gigliotti AR, Haupt R, Calevo MG. HCV infection in very long-term survivors after cancer chemotherapy and bone marrow transplantation a single-center experience. J Pediatr Hematol Oncol 2005; 27: 481–485
- Leung NW. Management of viral hepatitis C. J Gastroentrol Hepatol 2002; 17: 46–54
- Cesaro S, Petris MG, Rossetti F, Cusinato R, Pipan C. Chronic hepatitis C virus infection after treatment for pediatric malignancy. Blood 1997; 90: 1315–1320
- Locasciulli A, Testa M, Pontisso P, Benvegnu L. Prevalence and natural history of hepatitis C infection in patients cured of childhood leukemia. Blood 1997; 90: 4628–4633
- Castellino S, Lensing S, Riely C, Rai SN, Davila R, Randall T. The epidemiology of chronic hepatitis C infection in survivors of childhood cancer. Blood 2004; 103: 2460–2466
- Delwaide J, El Saouda R, Gerard C. Hepatitis C infection: eligibility for antiviral therapies. Eur J Gastroenterol Hepatol 2005; 17: 1185–1189
- Strader D, Wright T, Thomas D, Seef L. Diagnosis, management and treatment of hepatitis C: AASLD practice guideline. Hepatology 2004; 39: 1147–1171
- Lackner H, Moser A, Deutsh J, Harald H. Interferon-alpha and ribavirin in treating children and young adults with chronic hepatitis C after malignancy. Pediatrics 2000; 106: 53
- Cesaro S, Rossetti F, De Moliner L, Crivellaro C. Interferon for chronic hepatitis C in patients cured of malignancy. Eur J Pediatr 1994; 153: 153
- Yuce A, Kocak N, Gurakan F, Ozen H. Interferon-alpha treatment for chronic hepatitis C in children. Turk J Pediatr 2000; 42: 34–38